The Valley Desk

NCT02116777 · Interventional trial

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Overall registry status Completed

Phase 1 · Phase 2

Conditions Adult Solid Neoplasm, Childhood Solid Neoplasm, Recurrent Childhood Central Nervous System Neoplasm, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Malignant Solid Neoplasm, Refractory Central Nervous System Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov